SpineGuard Past Earnings Performance

Past criteria checks 0/6

SpineGuard's earnings have been declining at an average annual rate of -4.1%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been declining at an average rate of 10.6% per year.

Key information

-4.1%

Earnings growth rate

42.7%

EPS growth rate

Medical Equipment Industry Growth21.6%
Revenue growth rate-10.6%
Return on equity-51.5%
Net Margin-61.0%
Next Earnings Update17 Apr 2024

Recent past performance updates

Recent updates

Does SpineGuard (EPA:ALSGD) Have A Healthy Balance Sheet?

Sep 30
Does SpineGuard (EPA:ALSGD) Have A Healthy Balance Sheet?

Is SpineGuard (EPA:ALSGD) Using Debt Sensibly?

Sep 26
Is SpineGuard (EPA:ALSGD) Using Debt Sensibly?

Is SpineGuard (EPA:ALSGD) A Risky Investment?

May 10
Is SpineGuard (EPA:ALSGD) A Risky Investment?

Is SpineGuard (EPA:ALSGD) Using Debt Sensibly?

Nov 22
Is SpineGuard (EPA:ALSGD) Using Debt Sensibly?

Revenue & Expenses Breakdown
Beta

How SpineGuard makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ALSGD Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 235-361
31 Mar 235-361
31 Dec 226-251
30 Sep 225-251
30 Jun 225-251
31 Mar 225-241
31 Dec 214-241
30 Sep 215-241
30 Jun 215-241
31 Mar 215-241
31 Dec 205-341
30 Sep 205-241
30 Jun 206-151
31 Mar 206-151
31 Dec 197-151
30 Sep 197-161
30 Jun 197-261
31 Mar 197-261
31 Dec 188-271
30 Sep 188-371
30 Jun 188-371
31 Mar 188-481
31 Dec 178-481
30 Sep 178-481
30 Jun 178-491
31 Mar 178-491
31 Dec 167-491
30 Sep 167-491
30 Jun 167-491
31 Mar 167-491
31 Dec 156-481
30 Sep 156-481
30 Jun 155-481
31 Mar 155-481
31 Dec 144-571
30 Sep 144-471
30 Jun 144-471
31 Mar 145-471
31 Dec 135-461
30 Sep 134-361
30 Jun 134-361
31 Mar 134-361

Quality Earnings: ALSGD is currently unprofitable.

Growing Profit Margin: ALSGD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ALSGD is unprofitable, and losses have increased over the past 5 years at a rate of 4.1% per year.

Accelerating Growth: Unable to compare ALSGD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALSGD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.4%).


Return on Equity

High ROE: ALSGD has a negative Return on Equity (-51.46%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.